Seana Carson - Feb 29, 2024 Form 4 Insider Report for Bausch Health Companies Inc. (BHC)

Signature
/s/ Brianna M. Cetrulo, attorney-in-fact
Stock symbol
BHC
Transactions as of
Feb 29, 2024
Transactions value $
-$301,631
Form type
4
Date filed
3/4/2024, 04:16 PM
Previous filing
Dec 5, 2023
Next filing
Sep 9, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BHC Common Shares, No Par Value Award $0 +148K +38.53% $0.00 530K Feb 29, 2024 Direct F1
transaction BHC Common Shares, No Par Value Tax liability -$7.57K -765 -0.14% $9.89 530K Mar 1, 2024 Direct F2
transaction BHC Common Shares, No Par Value Tax liability -$59.3K -5.99K -1.13% $9.89 524K Mar 1, 2024 Direct F2
transaction BHC Common Shares, No Par Value Tax liability -$168K -17K -3.24% $9.89 507K Mar 1, 2024 Direct F2
transaction BHC Common Shares, No Par Value Tax liability -$5.05K -511 -0.1% $9.89 506K Mar 1, 2024 Direct F2
transaction BHC Common Shares, No Par Value Sale -$43.3K -4.42K -0.87% $9.80 502K Mar 4, 2024 Direct F3
transaction BHC Common Shares, No Par Value Sale -$1.95K -199 -0.04% $9.80 502K Mar 4, 2024 Direct F3
transaction BHC Common Shares, No Par Value Sale -$15.3K -1.56K -0.31% $9.80 500K Mar 4, 2024 Direct F3
transaction BHC Common Shares, No Par Value Sale -$1.3K -133 -0.03% $9.80 500K Mar 4, 2024 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc.
F2 This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.
F3 Represents shares of common stock sold in the open market pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on November 6, 2023.